Acer Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Acer Therapeutics

03/03/2022 11:12

* Acer Therapeutics Inc  ACER.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of one cent per share.
    * Revenue was $360.00 thousand​;  analysts expected $3.33
million. 
    * Acer Therapeutics Inc's reported EPS for the quarter was a
loss
of 31 cents​.
    * The mean earnings estimate of analysts had risen by
about 95.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Acer Therapeutics Inc shares had risen by 7.0% this
quarter.
    * The company reported a quarterly loss of $4.42 million.
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 3 at 11:11 a.m.  ​All
figures in US dollars unless otherwise stated